The Latest Breaking News from Clinical Trial

Six Cancer Drug Approvals in One Quarter: What the FDA Cleared in Q2 2026 and Who It Helps

FDA approved 6 cancer drugs in Q2 2026, covering breast, prostate, kidney, bladder, and blood cancers. Here's what was approved, who qualifies, and what it means.

Medical Daily · Jul 17

Serum Institute partners with Gates MRI to make experimental TB vaccine

Serum Institute will manufacture an experimental tuberculosis vaccine. This novel vaccine candidate is currently in late-stage clinical trials. Gates Medical Research Institute will transfer manufacturing technology and know-how. The company plans to invest over one hundred million dollars for production. This new shot could prevent millions of cases and save…

The Economic Times · Jul 16

Ozempic's Active Ingredient May Slow Biological Aging, First Human Clinical Trial Finds

A clinical trial published in Nature Communications found semaglutide slowed biological aging markers in adults with HIV. Here's what the research actually shows.

Medical Daily · Jul 15

Eating Only Two Meals a Day Changes Your Metabolism, Here Is What Happens Over Time

Your Hunger Hormones Shift FirstWithin the first week of eating only two meals a day, ghrelin, the hormone that triggers hunger, begins to recalibrate its peak times. Instead of spiking at your old breakfast hour, it gradually aligns with your new first meal window. A 2019 study published in Obesity…

Times Life · Jul 13

Brexit denies UK children access to life-extending drug for aggressive brain cancer

Exclusive: Experts say Brexit has led to delays in the launch of clinical trials and increased costs for multiple drugs. They are urging the government to reset the UK’s relationship with Europe to reopen access to potentially life-changing treatments

The Independent UK · Jul 12

How Poor Dental Health Slowly Destroys Your Gut Microbiome and Digestion Over Time

Your mouth is your gut's front doorThe average adult swallows roughly 1.5 litres of saliva every day. Every millilitre carries millions of microorganisms. When your oral microbiome is balanced, that constant swallowing is harmless, most oral bacteria are acid-sensitive and die in the stomach. When your mouth is colonised by…

Times Life · Jul 10

AstraZeneca Shares Sink After Heart Drug Trial Miss. Rare Clinical Setback Tests Investor Confidence

AstraZeneca shares fell sharply Thursday after the pharmaceutical giant reported that its experimental use of Wainua failed to achieve the primary endpoint in a late-stage clinical trial for a rare heart disease.

International Business Times · Jul 9

A Shot Every Two Weeks Instead of Weekly: New GLP-1 Drug Shows Strong Trial Results

A new biweekly GLP-1 drug called bofanglutide showed strong blood sugar and weight loss results in a Phase 2b trial. Monthly injectables and oral pills are also in the pipeline.

Medical Daily · Jul 9

Global Market: European shares rebound as tech stocks recover; investors assess Middle East developments

European stock markets traded higher on Thursday, recovering from previous losses. Technology shares led the gains, driven by renewed interest in artificial intelligence demand. Oil prices eased despite ongoing geopolitical uncertainty in the Middle East region. Spanish equities outperformed regional peers after trade-related tensions eased. AstraZeneca shares tumbled significantly after…

The Economic Times · Jul 9

GLP-1 Drugs Are Now Being Tested Alongside Chemotherapy in Cancer Patients

A University of Arizona trial is testing GLP-1 drugs with chemotherapy in metastatic pancreatic, colorectal, and liver cancer patients. Here's what the study asks.

Medical Daily · Jul 9